Sware
PrivateLast Round
Series B
Jun 6, 2024
Total Funding Raised
$6M
Momentum Score
25 /100
Company Overview
Sware is a regulatory technology company that provides a software validation platform, Res_Q, for the life sciences industry. The platform is designed to help pharmaceutical, medical device, and biotechnology companies automate, integrate, and scale their computer systems validation (CSV) processes to ensure compliance with GxP requirements. Sware's mission is to eliminate 'validation debt'—the accumulated cost of testing, release, and regulatory requirements—allowing companies to bring innovations to market more efficiently and safely. The company is venture-backed, having raised a total of approximately $26 million through a Series B funding round.
Sector
Healthcare & Life Sciences
Verticals
RegTech, Compliance, Vertical SaaS, Workflow Automation, Quality Management
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sware Comps
Public and private peers based on sector, stage, and business model.
Sware Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 6, 2024 |
Sware Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| First Analysis | Series B |
| Newstack Ventures | Series B |
| LRVHealth | Series B |
| Insight Partners | Series B |
Sware Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sware's valuation, stock price, and market status.
